Who
Yann Echelard
Director
Company insider
Files Form 4 as: Director, TG Therapeutics.
In numbers
- Trades disclosed
- 21
- Buys
- 1
- Sells
- 4
- Bought
- $96K
- Sold
- $2.2M
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 Mar 2013
- Last trade
- 11 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 15 Jun 2026 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,325 at $0.00 | filing |
| 11 Jun 2026filed 15 Jun 2026 | TGTX TG Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,325 at $0.00 | filing |
| 24 Nov 2025filed 25 Nov 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $163K5,000 at $32.57 | filing |
| 13 Jun 2025filed 16 Jun 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $369K10,000 at $36.94 | filing |
| 12 Jun 2025filed 16 Jun 2025 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —14,718 at $0.00 | filing |
| 5 Nov 2024filed 7 Nov 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $490K20,000 at $24.48 | filing |
| 19 Jun 2024filed 20 Jun 2024 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —22,250 at $0.00 | filing |
| 28 Sep 2023filed 29 Sep 2023 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 6 Jan 2023filed 6 Jan 2023 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Bought | $96K9,000 at $10.64 | filing |
| 20 Jul 2022filed 22 Jul 2022 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —43,732 at $0.00 | filing |
| 18 Jun 2021filed 22 Jun 2021 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
| 10 Dec 2020filed 11 Dec 2020 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Sold | $1.2M30,000 at $40.05 | filing |
| 22 Jun 2020filed 24 Jun 2020 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 17 Sep 2019filed 18 Sep 2019 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —27,048 at $0.00 | filing |
| 26 Jun 2018filed 28 Jun 2018 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 16 Jun 2017filed 19 Jun 2017 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 6 Jul 2016filed 8 Jul 2016 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —12,459 at $0.00 | filing |
| 4 Jun 2015filed 8 Jun 2015 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —4,667 at $0.00 | filing |
| 6 Jun 2014filed 10 Jun 2014 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —11,538 at $0.00 | filing |
| 5 Jun 2013filed 7 Jun 2013 | TGTX TG TherapeuticsBiotechnology | SEC FORM 4 Code A | —8,404 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.